Press Releases

 Filter by Provider

PBX Token officially launched on 20 October 2025 as the native utility asset behind a blockchain-based iGaming platform designed to redefine how users interact with decentralized gaming.

Happiness Brewed, the coffee and tea shop born from viral social media content about happiness and joyful moments, continues to demonstrate how brands can successfully align commerce with positive values. With content that has reached over 85 million views and an Instagram community of 27,200 followers, the company remains focused on helping people incorporate meaningful happiness practices into their daily routines.

DALLAS, Oct. 17, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of CSW Industrials, Inc. (NYSE: CSW) today declared a regular quarterly cash dividend of $0.27 per share. The dividend is payable on November 14, 2025, to shareholders of record as of the close of business on October 31, 2025.

Keysight Technologies, Inc. (NYSE: KEYS), announced the completion of its acquisition of the Optical Solutions Group from Synopsys, Inc. (NASDAQ: SNPS), and PowerArtist from Ansys, Inc. These acquisitions complement and expand Keysight’s design engineering software portfolio and computer-aided engineering capabilities, enabling customers to take innovative designs to market faster.

The Arena Group Holdings, Inc. (NYSE American: AREN) (“The Arena Group” or the “Company”), has acquired the intellectual property of ShopHQ from IV Media, LLC. The Arena Group plans to build on the legacy of the 35-year-old brand with a primary focus on E-Commerce and interactive selling.

The Bancorp, Inc. (“Bancorp”) (NASDAQ: TBBK) today announced that it will release its third quarter 2025 financial results after market hours on Thursday, October 30, 2025, and invites investors and other interested parties to listen to its earnings results conference call on Friday, October 31, 2025, at 8:00 a.m. Eastern time.

BOCA RATON, FL, Oct. 17, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced the publication of its latest research report, “The Next Best Crypto Trade? Solana DATs,” analyzing how Solana-based Digital Asset Treasuries (DATs) may represent the most compelling structural trade setup in today’s crypto markets.

With new stores across Washington and Oregon opening in November, locals and visitors across the region can enjoy shopping Five Below’s extensive assortment of trend-right finds, brands kids love and everyday unbeatable deals

SOUTH SAN FRANCISCO, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchase an aggregate of 27,400 shares of the Company’s stock (the “Inducement Grant”) to newly hired employees on October 15, 2025 (the “Grant Date”), in connection with the commencement of employment.

LOS ANGELES, Oct. 17, 2025 (GLOBE NEWSWIRE) -- via IBN – Nightfood Holdings, Inc. (OTCQB: NGTF) dba TechForce Robotics, a hospitality technology company integrating AI-driven robotics with hotel ownership, announces today that it is generating approximately $10 million in annualized revenue through its diversified portfolio of income-producing robotics and hospitality assets.

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 17, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced the acquisition of 9.25648743 Bitcoin (“BTC”) for an aggregate purchase price of $1,005,000 (gross of fees), at an average acquisition price of $108,301.75 per BTC. Following this transaction, CDT’s total Bitcoin holdings now stand at 17.9090111 BTC.

Shanghai, China, 17th Oct 2025 — Recently, Agibot has officially launched Genie Envisioner (GE), a unified world model platform for real-world robot control. Departing from the traditional fragmented pipeline of data-training-evaluation, GE integrates future frame prediction, policy learning, and simulation evaluation for the first time into a closed-loop architecture centered on video generation. This enables robots to perform end-to-end reasoning and execution—from seeing to thinking to acting—within the same world model. Trained on 3,000 hours of real robot data, GE-Act not only significantly surpasses existing State-of-The-Art (SOTA) methods in cross-platform generalization and long-horizon task execution but also opens up a new technical pathway for embodied intelligence from visual understanding to action execution.

The "Facioscapulohumeral Muscular Dystrophy Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.

Toronto, Ontario--(Newsfile Corp. - October 17, 2025) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a...

Dubai, United Arab Emirates--(Newsfile Corp. - October 17, 2025) - In a space where small and medium-sized enterprises (SMEs) struggle...

The "Ultrasonic Cleaner Market Research Report 2025-2030" report has been added to ResearchAndMarkets.com's offering.

The "Greece Existing & Upcoming Data Center Portfolio" database has been added to ResearchAndMarkets.com's offering.

VANCOUVER, BC, AL / ACCESS Newswire / October 17, 2025 / Rockhaven Resources Ltd. (TSXV:RK) ("Rockhaven") is pleased to announce the appointment of Cal Everett and Axemen Resource Capital as Financial Advisors.

Marcus & Millichap, Inc. (NYSE: MMI), a leading national brokerage firm specializing in commercial real estate investment sales, financing and research and advisory services, announced today it will report its financial results for the third quarter ended September 30, 2025 on Friday, November 7, 2025, before the market open.

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the new indication for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassemia.

NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2025 of $0.22 per Class A ordinary share.

Positive results from the POTOMAC Phase III trial showed adding one year of treatment with AstraZeneca’s IMFINZI® (durvalumab) to BCG induction and maintenance therapy demonstrated a statistically significant and clinically meaningful improvement in disease-free survival (DFS) for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer (NMIBC) compared to BCG treatment alone.

Shanghai, China, 17th Oct 2025 — Recently, Agibot officially launched the “Genie Trailblazer Global Recruitment Program”, aiming to invite top researchers worldwide to collaboratively define and create artificial intelligence capable of perceiving, reasoning, and emotionally engaging with the physical world.

Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will report third quarter 2025 financial results on October 31, 2025 before the market opens.

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced Yasmine Wasfi, M.D., Ph.D., FCCP has been promoted to CMO, effective immediately. She succeeds Ray Pratt, M.D., FACP who will transition from his current role to Senior Medical Advisor. Dr. Wasfi will report directly to the Company’s Chair and Chief Executive Officer and will serve as a member of the executive leadership team. Previously, Dr. Wasfi was Executive Vice President, Head of Clinical Development and Clinical Operations at Savara.

BALA CYNWYD, Pa., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Samsung Electronics Co., Ltd. today announced that it has acquired Xealth, the leading digital health platform that brings diverse digital tools and care programs that benefit patients and providers. The combined entity will help advance Samsung’s vision for connected care, taking a seamless and holistic approach to preventative care to as many people as possible.

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced a lineup of presentations at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin taking place October 17-21, 2025. Meeting attendees can review the following presentations to learn about ClearNote Health’s innovative early cancer detection technology and latest clinical research success.

Setting up a how to set up jewelry business can be a thrilling and profitable experience worldwide, where craftsmanship and design are highly valued. Whether you want to set up a boutique, an online store, or a private label brand, this guide will help you with the basic steps to start a jewelry business. 1. […]

Introduction Restaurants, cafes, catering, and takeout businesses are adopting Bagasse takeout plates and clamshell containers for takeout meals. Disposable Bagasse plates are among the most functional and inexpensive eco-friendly food service options. Food industry wholesalers and B2B suppliers in the food industry need to understand the demand in the market, the required level of eco-sustainability, […]

As a baby products retailer, your mission extends beyond simply selling items; you are curating the foundation of a family’s most precious early years. While consumables like diapers and wipes guarantee foot traffic and repeat business, it is the baby furniture department that truly defines your store’s brand, builds significant customer trust, and drives your […]

The global demand for even evening dresses and special occasion dresses has surged, signaling a renewed consumer preference for sophistication and timeless elegance in women’s formal wear. Fashion retailer Mondressy has been at the forefront of this shift, offering one of the industry’s most diverse and stylish collections of formal dresses that cater to every occasion, from weddings and red-carpet galas to milestone celebrations.

TORONTO, ON / ACCESS Newswire / October 17, 2025 / Long-term investors talk about proof like it's a milestone. In reality, proof is pressure. It's the moment when a company's story collides with execution, when plans meet reality, and when the market stops asking if something works and starts watching to see how it holds up. Akanda Corp. (NASDAQ:AKAN) is living that moment right now.

"The Critical Minerals and ZEO Company"

The acquisition combines Manatee's family-first clinical platform with Happypillar's technology to deliver more accessible, personalized mental health care for families nationwide.

TOKYO, JP / ACCESS Newswire / October 17, 2025 / Harrison Global Holdings Inc. (NASDAQ:BLMZ) today announced it has entered a binding term sheet with White Lion Capital LLC to establish a Bitcoin Purchase Agreement, representing a key milestone in the company's strategic expansion into the digital asset space. This agreement also signals the launch of Harrison Global's Bitcoin Treasury Strategy, a forward-looking approach to integrating Bitcoin as a core component of its balance sheet.

SAN JOSE, CALIFORNIA / ACCESS Newswire / October 17, 2025 / Peraso Inc. (NASDAQ:PRSO) ("Peraso" or the "Company"), a pioneer in mmWave wireless technology solutions, today announced it has received additional non-cancelable purchase orders totaling $0.5 million. These orders represent unanticipated incremental last-time buys associated with the previously announced end-of-life ("EOL") program for the Company's memory integrated circuit products. Peraso has begun fulfilling these orders from inventory and expects shipments to be completed during the fourth quarter of 2025.

TF Stairs introduces expanded custom stair tread solutions designed for Florida's luxury homes, combining craftsmanship, innovation, and timeless design to elevate modern and traditional spaces.

Oklo Inc. (NYSE: OKLO) (“Oklo”), an advanced nuclear technology company, and newcleo, a European developer of advanced nuclear reactors, today announced a joint agreement to develop advanced fuel fabrication and manufacturing infrastructure in the United States. Subject to customary approvals, newcleo plans to invest up to $2 billion via a newcleo-affiliated investment vehicle. Blykalla, Sweden's advanced nuclear technology developer, is also considering co-investing in the same projects, and procuring fuel related services from the projects.

Positive results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca’s IMFINZI® (durvalumab) in combination with standard-of-care FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) chemotherapy demonstrated a statistically significant and clinically meaningful improvement in the key secondary endpoint of overall survival (OS) versus chemotherapy alone. Patients were treated with neoadjuvant IMFINZI in combination with chemotherapy before surgery, followed by adjuvant IMFINZI in combination with chemotherapy, then IMFINZI monotherapy. The trial evaluated this regimen versus perioperative chemotherapy alone for patients with resectable, early-stage and locally advanced (Stages II, III, IVA) gastric and gastroesophageal junction (GEJ) cancers.

The following Funds announced today their share repurchase activity during the third quarter of 2025.

Treasure Data, the Intelligent Customer Data Platform (CDP) built for enterprise scale, announced today that it has achieved the Amazon Web Services (AWS) Generative AI Competency. This specialization recognizes Treasure Data as an AWS Partner that helps customers and the AWS Partner Network drive the advancement of services, tools, and infrastructure pivotal for implementing generative AI technologies.

Venu Holding Corporation ("VENU" or the "Company") (NYSE American: VENU), the disruptive live entertainment and hospitality company, announced today that it has launched its “Artist 280” travel services. Through its relationship with an FAA-certified air charter operator, VENU is now able to provide access to first-class private air and travel services to some of the music industry’s leading stars and bands performing at some of the Company’s iconic venues, such as the Pollstar-nominated Ford Amphitheater in Colorado Springs, the Sunset Amphitheater in Tulsa and VENU’s initial Texas collection of amphitheaters in McKinney (Dallas) and El Paso.

Newegg Business, a division of Newegg Commerce, Inc. (NASDAQ: NEGG), a leading provider of IT, computer hardware, and electronics solutions, today announced a new partnership with Credit Key, a leading B2B financing provider. This collaboration empowers businesses to access the technology they need immediately while enjoying flexible payment terms from Net 30 to extended-term options up to 12 months that support growth and financial stability.

CatalYm, a world-leader in neutralizing GDF-15 in cancer and cachexia, today presented compelling primary results from the Phase 2 GDFATHER-NEO trial in an oral late-breaking session at the European Society of Medical Oncology (ESMO) Congress 2025. The data demonstrated that Growth Differentiation Factor-15 (GDF-15) blockade by visugromab enhanced the efficacy of PD-1 inhibition by nivolumab as a neoadjuvant therapy in muscle-invasive bladder cancer (MIBC), with a similar safety profile compared to nivolumab plus placebo. Visugromab is a humanized, monoclonal antibody designed to neutralize the tumor-derived cytokine GDF-15 which plays a central role in immune suppression and anti-PD-(L)1 treatment resistance.

Clarion Partners Real Estate Income Fund Inc. (the “Fund”) Class S Shares (CPRSX), Class T Shares (CPRTX), Class D Shares (CPRDX) and Class I Shares (CPREX) announced today the results of its issuer tender offer for up to 5.0% of the Fund’s aggregate net asset value (“NAV”), or $53.8 million (calculated as of the NAV as of September 4, 2025), at a price per share equal to the NAV per share of each class of common stock (a “Share”) as of the close of the trading session on the New York Stock Exchange on October 15, 2025, the date on which the tender offer expired (the “Expiration Date”). The tendered Shares represent 3.2% of the Fund’s NAV calculated as of September 4, 2025.

Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAAR’s outstanding common shares, urges its fellow shareholders to vote on its GREEN Proxy Card “AGAINST” the proposed acquisition of STAAR by Alcon Inc. (“Alcon”) (NYSE: ALC) on the terms announced on August 5, 2025.

The Alliant Energy Corporation (NASDAQ: LNT) Board of Directors yesterday declared a quarterly cash dividend of $0.5075 per share payable on November 17, 2025, to shareowners of record as of the close of business on October 31, 2025.

Just under three in 10 (28.8%) U.S. homebuyers paid in all cash in August, down just incrementally from 29% a year earlier, according to a new report from Redfin, the real estate brokerage powered by Rocket.

Cary Street Partners, a leading wealth management firm, is proud to announce that Michael Saul has joined as Financial Advisor, Managing Director in its rapidly growing Morristown, New Jersey office. With more than 30 years of experience, Michael Saul has built his career on guiding individuals and families through life’s financial journey with clarity, confidence, and a strong fiduciary commitment to always act in the clients’ best interests.